Researchers are exploring new strategies for safer and more effective cancer immunotherapy through the smart control of CAR-T cells. Various approaches are being developed, including engineering CAR-T cells with specific proteins or using drugs to control their activity. The goal of these emerging strategies is to improve the treatment of cancers, including solid tumors and biliary tract cancer, although the details and outcomes of these approaches are still being investigated.